LTR Pharma Past Earnings Performance

Past criteria checks 0/6

LTR Pharma's earnings have been declining at an average annual rate of -67.4%, while the Pharmaceuticals industry saw earnings growing at 35.4% annually. Revenues have been growing at an average rate of 79.5% per year.

Key information

-67.4%

Earnings growth rate

-791.1%

EPS growth rate

Pharmaceuticals Industry Growth31.2%
Revenue growth rate79.5%
Return on equity-236.5%
Net Margin-14,192.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How LTR Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CHIA:LTP Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-734
31 Mar 240-523
31 Dec 230-312
30 Sep 230-211
30 Jun 230-111
30 Jun 220-110

Quality Earnings: LTP is currently unprofitable.

Growing Profit Margin: LTP is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if LTP's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare LTP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: LTP is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (46.5%).


Return on Equity

High ROE: LTP has a negative Return on Equity (-236.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies